Cargando…
Narrative Review: Low-Dose Ketamine for Pain Management
Pain is the leading cause of medical consultations and occurs in 50–70% of emergency department visits. To date, several drugs have been used to manage pain. The clinical use of ketamine began in the 1960s and it immediately emerged as a manageable and safe drug for sedation and anesthesia. The anal...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179418/ https://www.ncbi.nlm.nih.gov/pubmed/37176696 http://dx.doi.org/10.3390/jcm12093256 |
_version_ | 1785041093296914432 |
---|---|
author | Riccardi, Alessandro Guarino, Mario Serra, Sossio Spampinato, Michele Domenico Vanni, Simone Shiffer, Dana Voza, Antonio Fabbri, Andrea De Iaco, Fabio |
author_facet | Riccardi, Alessandro Guarino, Mario Serra, Sossio Spampinato, Michele Domenico Vanni, Simone Shiffer, Dana Voza, Antonio Fabbri, Andrea De Iaco, Fabio |
author_sort | Riccardi, Alessandro |
collection | PubMed |
description | Pain is the leading cause of medical consultations and occurs in 50–70% of emergency department visits. To date, several drugs have been used to manage pain. The clinical use of ketamine began in the 1960s and it immediately emerged as a manageable and safe drug for sedation and anesthesia. The analgesic properties of this drug were first reported shortly after its use; however, its psychomimetic effects have limited its use in emergency departments. Owing to the misuse and abuse of opioids in some countries worldwide, ketamine has become a versatile tool for sedation and analgesia. In this narrative review, ketamine’s role as an analgesic is discussed, with both known and new applications in various contexts (acute, chronic, and neuropathic pain), along with its strengths and weaknesses, especially in terms of psychomimetic, cardiovascular, and hepatic effects. Moreover, new scientific evidence has been reviewed on the use of additional drugs with ketamine, such as magnesium infusion for improving analgesia and clonidine for treating psychomimetic symptoms. Finally, this narrative review was refined by the experience of the Pain Group of the Italian Society of Emergency Medicine (SIMEU) in treating acute and chronic pain with acute manifestations in Italian Emergency Departments. |
format | Online Article Text |
id | pubmed-10179418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101794182023-05-13 Narrative Review: Low-Dose Ketamine for Pain Management Riccardi, Alessandro Guarino, Mario Serra, Sossio Spampinato, Michele Domenico Vanni, Simone Shiffer, Dana Voza, Antonio Fabbri, Andrea De Iaco, Fabio J Clin Med Review Pain is the leading cause of medical consultations and occurs in 50–70% of emergency department visits. To date, several drugs have been used to manage pain. The clinical use of ketamine began in the 1960s and it immediately emerged as a manageable and safe drug for sedation and anesthesia. The analgesic properties of this drug were first reported shortly after its use; however, its psychomimetic effects have limited its use in emergency departments. Owing to the misuse and abuse of opioids in some countries worldwide, ketamine has become a versatile tool for sedation and analgesia. In this narrative review, ketamine’s role as an analgesic is discussed, with both known and new applications in various contexts (acute, chronic, and neuropathic pain), along with its strengths and weaknesses, especially in terms of psychomimetic, cardiovascular, and hepatic effects. Moreover, new scientific evidence has been reviewed on the use of additional drugs with ketamine, such as magnesium infusion for improving analgesia and clonidine for treating psychomimetic symptoms. Finally, this narrative review was refined by the experience of the Pain Group of the Italian Society of Emergency Medicine (SIMEU) in treating acute and chronic pain with acute manifestations in Italian Emergency Departments. MDPI 2023-05-02 /pmc/articles/PMC10179418/ /pubmed/37176696 http://dx.doi.org/10.3390/jcm12093256 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Riccardi, Alessandro Guarino, Mario Serra, Sossio Spampinato, Michele Domenico Vanni, Simone Shiffer, Dana Voza, Antonio Fabbri, Andrea De Iaco, Fabio Narrative Review: Low-Dose Ketamine for Pain Management |
title | Narrative Review: Low-Dose Ketamine for Pain Management |
title_full | Narrative Review: Low-Dose Ketamine for Pain Management |
title_fullStr | Narrative Review: Low-Dose Ketamine for Pain Management |
title_full_unstemmed | Narrative Review: Low-Dose Ketamine for Pain Management |
title_short | Narrative Review: Low-Dose Ketamine for Pain Management |
title_sort | narrative review: low-dose ketamine for pain management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179418/ https://www.ncbi.nlm.nih.gov/pubmed/37176696 http://dx.doi.org/10.3390/jcm12093256 |
work_keys_str_mv | AT riccardialessandro narrativereviewlowdoseketamineforpainmanagement AT guarinomario narrativereviewlowdoseketamineforpainmanagement AT serrasossio narrativereviewlowdoseketamineforpainmanagement AT spampinatomicheledomenico narrativereviewlowdoseketamineforpainmanagement AT vannisimone narrativereviewlowdoseketamineforpainmanagement AT shifferdana narrativereviewlowdoseketamineforpainmanagement AT vozaantonio narrativereviewlowdoseketamineforpainmanagement AT fabbriandrea narrativereviewlowdoseketamineforpainmanagement AT deiacofabio narrativereviewlowdoseketamineforpainmanagement |